Eye Kare Kilitch Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 5.00 Cr
as on 16-11-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 73.23%
(FY 2023)
- Ebitda 73.23%
(FY 2023)
- Net Worth -11.88%
(FY 2023)
- Total Assets -25.32%
(FY 2023)
About Eye Kare Kilitch
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Paresh Mehta, Neha Mehta, Mukesh Shah, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24297MH2009PLC198224
- Company No.
198224
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
31 Dec 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Eye Kare Kilitch?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Paresh Mehta  | Managing Director | 31-Dec-2009 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mukesh Agashiwala | Director | 01-Dec-2014 | Current |
| Divya Mehta | Director | 14-May-2013 | Current |
| Neha Mehta | Director | 14-May-2013 | Current |
| Mukesh Shah | Director | 30-Jun-2010 | Current |
| Pradyumna Pande | Director | 27-May-2014 | Current |
Financial Performance and Corporate Structure Insights of Eye Kare Kilitch.
Eye Kare Kilitch Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 73.23% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eye Kare Kilitch?
In 2023, Eye Kare Kilitch had a promoter holding of 93.30% and a public holding of 6.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kilitch Healthcare India LimitedActive 26 years 5 daysParesh Mehta, Neha Mehta and 2 more are mutual person
Kilitch Healthcare LlpActive 12 years 2 monthsParesh Mehta, Neha Mehta and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eye Kare Kilitch?
Eye Kare Kilitch has a workforce of 55 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eye Kare Kilitch, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eye Kare Kilitch's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
